Bioanalytical methods for quantification of Bevacizumab in human serum: ELISA versus MSD.
- DOI
- 10.1016/j.bbrep.2026.102465
- Published
- 2026 Mar
- Container
- Biochemistry and biophysics reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bbrep.2026.102465,
title = {Bioanalytical methods for quantification of Bevacizumab in human serum: ELISA versus MSD.},
author = {Chandnani V and Tiwari S and Bob M and Vasantharaju SG and Ravi G and Supraja A and Pawar A and Khandave S and Jagtap S and Sathyanarayana MB},
year = {2026},
journal = {Biochemistry and biophysics reports},
doi = {10.1016/j.bbrep.2026.102465},
url = {https://doi.org/10.1016/j.bbrep.2026.102465}
}RIS
TY - JOUR TI - Bioanalytical methods for quantification of Bevacizumab in human serum: ELISA versus MSD. AU - Chandnani V AU - Tiwari S AU - Bob M AU - Vasantharaju SG AU - Ravi G AU - Supraja A AU - Pawar A AU - Khandave S AU - Jagtap S AU - Sathyanarayana MB PY - 2026 JO - Biochemistry and biophysics reports DO - 10.1016/j.bbrep.2026.102465 UR - https://doi.org/10.1016/j.bbrep.2026.102465 ER -
APA
V, C., S, T., M, B., SG, V., G, R., A, S., A, P., S, K., S, J., & MB, S. (2026). Bioanalytical methods for quantification of Bevacizumab in human serum: ELISA versus MSD.. Biochemistry and biophysics reports. https://doi.org/10.1016/j.bbrep.2026.102465
Source records
- pubmed · retrieved 2026-09-25T04:19:17.736Z